Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - OTHER CURRENT ASSETS
Other Current Assets KYMR - Kymera Therapeutics, Inc.
11.7 M
LAST VALUE
15.70%
2 YEAR CAGR
98.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR